Haviv YS - Search Results

1

DNA-free recombinant SV40 capsids protect mice from acute renal failure by inducing stress response, survival pathway and apoptotic arrest.

Butin-Israeli V, Uzi D, Abd-El-Latif M, Pizov G, Eden A, Haviv YS, Oppenheim A. Butin-Israeli V, et al. Among authors: haviv ys. PLoS One. 2008 Aug 20;3(8):e2998. doi: 10.1371/journal.pone.0002998. PLoS One. 2008. PMID: 18714386 Free PMC article.

2

Pancreatic acinar and islet cell infection by low-dose SV40 administration.

Shimony N, Bendayan M, Elkin G, Ben-nun-Shaul O, Abd-El-Latif M, Scherzer P, Arbel O, Ziv E, Krasny L, Pizov G, Oppenheim A, Haviv YS. Shimony N, et al. Among authors: haviv ys. Pancreas. 2008 May;36(4):411-6. doi: 10.1097/MPA.0b013e31815d349b. Pancreas. 2008. PMID: 18437088

3

Gene therapy for renal cancer.

Haviv YS, Curiel DT. Haviv YS, et al. Contrib Nephrol. 2008;159:135-150. doi: 10.1159/000125687. Contrib Nephrol. 2008. PMID: 18391590

4

A novel dynamic matrix detachment model reveals a shift from apoptosis to necrosis in melanoma cells.

Tzukert K, Gorodestky R, Avrahami I, Krasny L, Shimony N, Elkin G, Nettelbeck DM, Haviv YS. Tzukert K, et al. Among authors: haviv ys. Cancer Lett. 2008 Dec 18;272(2):345-54. doi: 10.1016/j.canlet.2008.07.012. Epub 2008 Aug 23. Cancer Lett. 2008. PMID: 18723276

5

The incidence and prognosis of renal dysfunction following cardioversion of atrial fibrillation.

Hellman Y, Cohen MJ, Leibowitz D, Loncar S, Gozal D, Haviv YS, Haber G, Afifi M, Rosenheck S, Lotan C, Pollak A, Gilon D. Hellman Y, et al. Among authors: haviv ys. Cardiology. 2013;124(3):184-9. doi: 10.1159/000346618. Epub 2013 Mar 9. Cardiology. 2013. PMID: 23485988

6

Analysis of adenoviral attachment to human platelets.

Shimony N, Elkin G, Kolodkin-Gal D, Krasny L, Urieli-Shoval S, Haviv YS. Shimony N, et al. Among authors: haviv ys. Virol J. 2009 Feb 17;6:25. doi: 10.1186/1743-422X-6-25. Virol J. 2009. PMID: 19222836 Free PMC article.

7

Admission of kidney patients to a closed staff nephrology department results in a better short-term survival.

Schwartz L, Rosenshtok O, Shalev L, Schneider E, Basok A, Vorobiov M, Romanjuk E, Rogachev B, El-Sayed I, Schwartz L, Menashe I, Regev O, Haviv YS. Schwartz L, et al. Among authors: haviv ys. PLoS One. 2023 Mar 7;18(3):e0279172. doi: 10.1371/journal.pone.0279172. eCollection 2023. PLoS One. 2023. PMID: 36881606 Free PMC article.

8

Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.

Haviv YS, van Houdt WJ, Lu B, Curiel DT, Zhu ZB. Haviv YS, et al. Mol Cancer Ther. 2004 Jun;3(6):687-91. Mol Cancer Ther. 2004. PMID: 15210854

9

A simplified in vitro ligation approach to clone an E1B55k-deleted double-targeted conditionally-replicative adenovirus.

Haviv YS. Haviv YS. Virol J. 2009 Feb 7;6:18. doi: 10.1186/1743-422X-6-18. Virol J. 2009. PMID: 19200390 Free PMC article.

10

An in-vitro tumour microenvironment model using adhesion to type I collagen reveals Akt-dependent radiation resistance in renal cancer cells.

Krasny L, Shimony N, Tzukert K, Gorodetsky R, Lecht S, Nettelbeck DM, Haviv YS. Krasny L, et al. Among authors: haviv ys. Nephrol Dial Transplant. 2010 Feb;25(2):373-80. doi: 10.1093/ndt/gfp525. Epub 2009 Oct 13. Nephrol Dial Transplant. 2010. PMID: 19828461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters